Revolution Medicines, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Revolution Medicines, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2025.

  • This data is from Revolution Medicines, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Revolution Medicines, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 100.0%.
  • Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2023: $11.58 million | Fiscal year 2022: $35.38 million | Fiscal year 2021: $29.39 million | Fiscal year 2020: $42.98 million | Fiscal year 2019: $50.04 million | Fiscal year 2018: $20.17 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: